Scope of translational medicine in developing boron-containing compounds for therapeutics

doi:10.5528/wjtm.v6.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12512)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

715

WORD

476

HTML

5539

Figures (1-5)

159

Sum=6889

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1496

Download

1923

Sum=3419

Publishing Process of This Article

Item

Count

Browse

953

Download

1251

Sum=2204

Apr 12, 2017 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Translational Medicine

ISSN

2220-6132

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Transl Med. Apr 12, 2017; 6(1): 1-9
Published online Apr 12, 2017. doi: 10.5528/wjtm.v6.i1.1

Full Size Figure Download Figure

Figure 2 Boronic acid-based proteasome inhibitors with relevance to medicinal chemistry.

Citation: García-Ávila AK, Farfán-García ED, Guevara-Salazar JA, Trujillo-Ferrara JG, Soriano-Ursúa MA. Scope of translational medicine in developing boron-containing compounds for therapeutics. World J Transl Med 2017; 6(1): 1-9
URL: https://www.wjgnet.com/2220-6132/full/v6/i1/1.htm
DOI: https://dx.doi.org/10.5528/wjtm.v6.i1.1